Lifestance Health
LFST · Health Care Services
$12.93
2.9%Tempus AI
TEM · Health Care Services
$67.62
6.0%The short version
- Lifestance Health is the larger business, with $1.4B of revenue in fiscal 2025 against $1.3B for Tempus AI.
- Tempus AI grew revenue faster (83.4%, against 13.9%).
- Lifestance Health kept more of each dollar of sales as operating profit (1.7% operating margin, against −19.9% operating margin).
- Lifestance Health turned more of its sales into free cash flow (7.7% FCF margin, against −18.8% FCF margin).
| Latest fiscal year | LFST · FY25 | TEM · FY25 |
|---|---|---|
| Size | ||
| Market cap | $5.0B | $13.5M |
| Revenue | $1.4B | $1.3B |
| Free cash flow | $110M | −$239M |
| Net income | $9.7M | −$245M |
| Growth | ||
| Revenue growth | 13.9% | 83.4% |
| 5-year growth | 46.3% | — |
| Share count change | 3.2% | 45.4% |
| Profitability | ||
| Gross margin | — | — |
| Operating margin | 1.7% | −19.9% |
| Net margin | 0.7% | −19.3% |
| FCF margin | 7.7% | −18.8% |
| Return on capital | 1.2% | — |
| Return on equity | 0.7% | −89.5% |
| Balance sheet | ||
| Net debt | $34.2M | −$396M |
| Net debt / EBITDA | 0.5x | — |
| Dividends and buybacks | $0.0M | $3.0M |
| Valuation & quality | ||
| P/E | 99.5x | — |
| Piotroski F-score | 7 | 5 |
FY19
LFST $213M
TEM —
FY21
LFST $668M
TEM —
FY22
LFST $860M
TEM $321M
FY23
LFST $1.1B
TEM $532M
FY24
LFST $1.3B
TEM $693M
FY25
LFST $1.4B
TEM $1.3B
LFST
TEM
FY19
LFST 7.2%
TEM —
FY21
LFST −42.9%
TEM —
FY22
LFST −24.5%
TEM −82.8%
FY23
LFST −17.9%
TEM −36.9%
FY24
LFST −2.5%
TEM −99.7%
FY25
LFST 1.7%
TEM −19.9%
LFST
TEM
FY19
LFST $2.7M
TEM —
FY21
LFST −$85.1M
TEM —
FY22
LFST −$26.5M
TEM −$187M
FY23
LFST −$57.4M
TEM −$249M
FY24
LFST $85.7M
TEM −$211M
FY25
LFST $110M
TEM −$239M
LFST
TEM
FY19
LFST —
TEM —
FY21
LFST —
TEM —
FY22
LFST −10.4%
TEM —
FY23
LFST −9.1%
TEM —
FY24
LFST −1.6%
TEM —
FY25
LFST 1.2%
TEM —
LFST
TEM
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.